Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
FEBS Lett ; 593(16): 2139-2150, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-31211853

RESUMO

The abnormal accumulation of ß-amyloid peptide (Aß) is recognized as a central component in the pathogenesis of Alzheimer disease. While many aspects of Aß-mediated neurotoxicity remain elusive, Aß has been associated with numerous underlying pathologies, including oxidative and nitrosative stress, inflammation, metal ion imbalance, mitochondrial dysfunction, and even tau pathology. Ergothioneine (ET), a naturally occurring thiol/thione-derivative of histidine, has demonstrated antioxidant and neuroprotective properties against various oxidative and neurotoxic stressors. This study investigates ET's potential to counteract Aß-toxicity in transgenic Caenorhabditis elegans overexpressing a human Aß peptide. The accumulation of Aß in this model leads to paralysis and premature death. We show that ET dose-dependently reduces Aß-oligomerization and extends the lifespan and healthspan of the nematodes.


Assuntos
Peptídeos beta-Amiloides/toxicidade , Antioxidantes/administração & dosagem , Caenorhabditis elegans/genética , Ergotioneína/administração & dosagem , Paralisia/prevenção & controle , Peptídeos beta-Amiloides/genética , Animais , Animais Geneticamente Modificados , Antioxidantes/farmacologia , Caenorhabditis elegans/efeitos dos fármacos , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Ergotioneína/farmacologia , Humanos , Estresse Oxidativo/efeitos dos fármacos , Paralisia/genética , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...